TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Levi & Korsinsky Notifies Shareholders of Telix Pharmaceuticals Ltd. (TLX) of a Class Action Lawsuit and an Upcoming Deadline

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Levi & Korsinsky, Llp
Levi & Korsinsky Notifies Shareholders of Telix Pharmaceuticals Ltd. (TLX) of a Class Action Lawsuit and an Upcoming Deadline

Levi & Korsinsky has filed a class action securities lawsuit against Telix Pharmaceuticals Ltd. on behalf of investors who suffered losses between February 21, 2025 and August 28, 2025. The complaint alleges that defendants made false statements regarding prostate cancer therapeutic progress, overstated supply chain quality, and made materially misleading statements about the company's business and prospects. The deadline to request lead plaintiff status is January 9, 2026.

Insights
NEM   neutral

Included in gold mining sector investment


TLX   negative

The company is the subject of a securities fraud class action lawsuit alleging material misstatements about prostate cancer therapeutic progress and supply chain quality, indicating serious allegations of corporate misconduct and investor harm.